- Home
- Romy Injection
Romy Injection Substitute
Verified Ingredients and Effects
Composition:
ROMIPLOSTIM-250MCG
Uses:
<p>Romy Injection is used in the treatment of immune thrombocytopenia (an immune disorder characterised by low platelet counts). The detailed uses of Romy Injection are as follows:</p><ul><li><strong>Treats Immune Thrombocytopenia (ITP):</strong> Romy Injection is primarily used in adults with chronic ITP and children with ITP lasting at least 6 months who have not responded adequately to treatments such as splenectomy (surgical removal of the spleen) or medications like corticosteroids and immunoglobulins.</li><li><strong>Reduces Bleeding Risk:</strong> Romy Injection helps prevent bleeding episodes by increasing platelet production, particularly in patients with persistent or recurrent ITP.</li><li><strong>Serves as a Steroid-Sparing Agent:</strong> Romy Injection may be used as an alternative to or in combination with corticosteroids to help reduce the need for long-term steroid treatment and minimise the risk of associated side effects in ITP patients.</li><li><strong>Manages Preoperative Thrombocytopenia:</strong> In certain cases, Romy Injection may be administered before surgical procedures in patients with ITP to temporarily increase platelet counts and reduce bleeding risks.</li></ul>
Medicinal Benefits:
Romy Injection contains 'Romiplostim' which belongs to the class of 'thrombopoietin receptor agonists' used to treat low blood platelet count in patients with immune thrombocytopenia. Romy Injection promotes platelet formation by activating the thrombopoietin receptor. Thereby, Romy Injection helps treat immune thrombocytopenia effectively.
FAQs
Romy Injection belongs to the class of 'platelet-stimulating agents' primarily used to treat chronic immune thrombocytopenia in adults who have had an insufficient response to corticosteroids, immunoglobulins, or splenectomy.
Romy Injection contains Romiplostim, which promotes platelet formation by activating the thrombopoietin receptor. Thus Romy Injection lowers the risk of bleeding episodes in diseases like immune thrombocytopenia and other associated conditions.
Immune thrombocytopenia is an autoimmune disorder in which the immune system misidentifies platelets as foreign bodies and destroys them. It can occur due to a virus, vaccination, or certain drugs. But the origin is unknown in the majority of cases.
Romy Injection is only advised for patients who have not responded adequately to other treatments such as corticosteroids, immunoglobulins, or splenectomy.
Idiopathic thrombocytopenic purpura is typically diagnosed with blood tests such as complete blood count and antiplatelet-antibody test.
Romy Injection is not approved to treat thrombocytopenia caused by Myelodysplastic syndrome (MDS) or any other cause of thrombocytopenia apart from chronic ITP.
